The global single cell analysis market is estimated to grow at CAGR of 18.5% during 2016-2022. The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centers, hospitals and diagnostic laboratories and research & academic laboratories. the cell type segment is segmented into animal cells, human cells and microbial cells.

The single cell analysis market is dominated by some of the major key players such as Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic’s PLC, Celgene Corporation, GE Healthcare, Illumina Inc., Merck KGAA, Nanostring technologies Inc., Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc.In 2015, the Medtronic has announced that they had completed the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices.

The Increased funding by government and private firms in research and development are snowballing the scope of single cell analysis market. Although the growing and increasing healthcare spending across the globe is also driving the growth in the global single cell analysis market. The rising prevalence of chronic diseases in the world are creating huge scope for single cell analysis market. However, the increasing technology advancement is one of the key factor which is generating huge scope in single cell analysis market. In last decade there are a lot of mergers, acquisition and other strategic initiative taken by various key players to develop the new technology in the single cell analysis market.

The single cell analysis market is majorly driven by growing geriatric population and prevalence of chronic diseases is increasing the scope of single cell analysis in the global market. However, the unwillingness among researchers to accept advanced single-cell analysis products and stringent government policies may hinder the growth in the global single cell analysis market. The global single cell analysis market is having huge opportunities such as huge growth opportunity in the emerging countries, growth potential in single-cell sequencing (SCS), fostering stem cell research is expected to contribute a lot in the growth of global single cell analysis market and untapped Asia pacific region has huge scope for single cell analysis market.

North America dominates the single cell analysis market, the domination is due to presence of some key player of single cell analysis who are dominating and contributing the large share in the global market. The growth of North America is driven by number of factors such as technological advancement, expansion in product innovation and increasing in number of patients of diabetes and orthopedic. APAC is the fastest growing region in the world. The APAC is growing with an impressive CAGR in the forecasted period. The growth is driven by growing demand for stem cell therapy is excepted to boost the Asia Pacific single cell analysis market. The growing demand for low cost treatment in the world is also injecting huge growth opportunity in the Asia Pacific region.